Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 25.70M | $ 24.30M | $ 25.10M | $ 25.70M | $ 21.50M |
Total Assets | $ 377.60M | $ 378.50M | $ 327.30M | $ 377.10M | $ 349.00M |
Total Debt | $ 124.00M | $ 106.80M | $ 81.00M | $ 89.90M | $ 51.10M |
Net Debt | $ 98.30M | $ 82.50M | $ 55.90M | $ 64.20M | $ 29.60M |
Total Liabilities | $ 288.20M | $ 216.70M | $ 194.10M | $ 265.70M | $ 219.00M |
Stockholders Equity | $ 70.00M | $ 143.80M | $ 115.70M | $ 95.00M | $ 113.30M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |